{
    "prompt": "Please provide each treatment as a json format with the following JSON schema.\n    {\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\":\n            \"Link to FDA-approved Label\": \n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0024765\nAge: 51\nGender: Female\nSample ID: P-0024765-T01-IM6\nGene Panel: IMPACT468\nCancer Type: Colon Adenocarcinoma\nSample Type: Primary\nTumor Purity: 50.0%\n=============\nDNA Variants:\nAPC c.694C>T (p.R232*) - in 24.00% of 729 reads\nAR c.1456C>A (p.P486T) - in 6.00% of 386 reads\nBRAF c.1799T>A (p.V600E) - in 24.00% of 796 reads\nETV6 c.1034T>C (p.V345A) - in 21.00% of 1193 reads\nMGA c.7303C>T (p.R2435W) - in 20.00% of 934 reads\nTP53 c.578A>T (p.H193L) - in 33.00% of 887 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Treatment 1\": {\n    \"Disease Name\": \"Colon Adenocarcinoma\",\n    \"Disease Phase or Condition\": \"Primary\",\n    \"Drug Name\": \"Vemurafenib\",\n    \"Prior Treatment or Resistance Status\": \"No prior treatment specified\",\n    \"Genomic Features\": \"BRAF V600E mutation\",\n    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202973s000lbl.pdf\"\n  }\n}"
}